Choose a result that matters.
Start with a bounded question and a functional outcome—not a vague wish to “optimise everything” or chase whichever device number happens to move.
Personal Science & Responsible Biohacking · successor candidate
Test the frontier. Keep the uncertainty.
Biohacking becomes useful when it stops being a collection of promises and becomes a careful question. Titan’s Personal Science method helps a person test one low-risk, reversible change against a real outcome—without turning a wearable reading into a diagnosis, a personal result into a universal claim or an exciting idea into a public protocol.
The definition
A disciplined way to ask, “Did this actually help?”
Titan defines responsible biohacking as the careful testing of a reversible biological, behavioural, environmental or technological change against a declared real-world outcome. It begins with the lowest-risk and least-invasive route, acknowledges measurement error and retains null, contradictory and adverse results.
Keep the comparison interpretable.
Record the baseline and context, change one main variable, and predeclare what would count as meaningful rather than explaining the result afterwards.
Keep null and adverse results.
Benefit observed, no meaningful change, inconclusive, excessive burden, harm and stopping early are all legitimate records. None is quietly rewritten as success.
What one personal comparison cannot do: diagnose a condition, prove an effect for everybody, establish that a biomarker change is meaningful, or make an unsafe intervention safe.
Architectural placement
A method across Titan. Not a twenty-fifth domain.
Personal Science sits across the Methods and Applications layer and is governed as one lane inside the subordinate Titan Research & Governance Lab. It can help test a bounded change connected to an existing outcome, but it is not a separate public product, does not alter Titan’s frozen 24-domain Core, add an operational Capability module or create a biohacking score.
Separate signal from noise.
The record names the measure, instrument, device or algorithm version, minimum meaningful change, minimum detectable change and important uncertainty.
Define before testing.
A promising idea needs a bounded claim, declared population and context, safety conditions, burden, stop rules and a real-world outcome before it can be examined.
Interesting is not operational.
Emerging, mixed or context-dependent ideas can remain visible without becoming advice. Evidence and counter-evidence travel together.
Rejected claims stay rejected.
Unsupported public language remains recorded so repetition, popularity, sponsorship or a new marketing cycle cannot quietly return it to the system.
Personal Science Standard
Twelve fields before a result earns an interpretation.
The method is intentionally more modest than a clinical trial and more disciplined than ordinary self-tracking. Titan uses “personal comparison” by default. “N-of-1 trial” is reserved for a prospectively planned repeated crossover with multiple periods, at least two conditions, declared allocation and carry-over or washout handling.
- Bounded questionState one answerable question before collecting results.
- Baseline + contextRecord the starting pattern, conditions, supports and constraints.
- One principal changeKeep the comparison interpretable by changing one main variable.
- Primary outcomeDeclare the result and minimum meaningful and detectable change in advance.
- MeasurementName the instrument or device version and how ordinary noise will be handled.
- Duration + washoutState the comparison periods and any carry-over concern.
- ConfoundersRecord sleep, illness, workload, environment, assistance and other plausible changes.
- Missing dataDecide how omissions and deviations will be treated before seeing the result.
- Stop rulesSet safety, burden, cost and withdrawal conditions before starting.
- All outcomesRetain null, inconclusive, burdensome and adverse results.
- Delayed retestPlan a comparable later check where retention matters.
- BoundaryState what the result does not establish about other people, contexts or devices.
Public-tool boundary
Useful self-observation. No do-it-yourself medicine.
Low-risk, reversible comparisons
- ordinary routine or environmental changes;
- baseline and comparable retest observations;
- direct tasks, structured observations, self-report or consumer-device measures with uncertainty;
- burden, cost, confounders, missing data and stop decisions;
- positive, null, inconclusive, adverse and stopped-early outcomes.
Clinical or high-risk intervention
- medication, hormone, psychoactive-substance or experimental-compound changes;
- clinical diagnosis, treatment or interpretation;
- extended fasting, hypoxia, pressure exposure or extreme heat or cold;
- invasive equipment, experimental peptides, brain stimulation or pharmacological longevity cycles;
- anything whose safe use depends on individual clinical assessment or specialist supervision.
The safest useful change comes first. If changing a tool, environment, schedule or support could answer the question, Titan does not treat a more invasive biological intervention as inherently more advanced.
Governed status map
Four states prevent biohacking from becoming one undifferentiated category.
A status belongs to a precise claim × intervention × population × outcome × context. It does not label an entire technology as universally good or bad.
Method, not treatment
Low-risk reversible comparisons, baseline and retest, declared measurement, uncertainty and retention of unfavourable results.
Qualified pathway
A legitimate topic may require clinical, professional or specialist assessment. Titan supplies boundaries, not a public protocol.
Not ready for guidance
Plausible, emerging, mixed or insufficiently replicated work stays visible without recommendation or promotion.
Public claim refused
The stated wording is unsupported, misleading, unsafe or materially stronger than the evidence permits.
Restricted topics
- Clinically indicated CGM and treatment interpretation
- Therapeutic light boxes
- Heat or cold beyond ordinary conditions
- Clinical neurofeedback
- Photobiomodulation for a diagnosed condition
- Hyperbaric oxygen therapy
- Breath retention, hypoxia or pressure exposure
- Restrictive diets, extended fasting or supplement protocols in illness
- Medication, hormone or psychoactive changes
- Clinical toxicology testing or treatment
Research Observatory topics
- Healthy-person CGM optimisation
- Sauna or passive heat for longevity
- Cold for longevity or general resilience
- Red-light or photobiomodulation enhancement
- General cognitive neurofeedback
- Epigenetic-age clocks
- Direct-to-consumer microbiome profiling
- Grounding or earthing
- NAD products, rapamycin or senolytics
- Experimental peptides and longevity pharmacology
- Psychedelic-assisted capability claims
Rejected public claims
- Generic detox or toxin-burden scores
- Sauna as proven toxin removal
- Public PFAS or microplastic clearing protocols
- Oat beta-glucan as an established PFAS treatment
- Non-invasive glucose watches or rings
- Readiness scores as diagnoses or prescriptions
- Universal HRV, glucose, sleep or light targets
- DIY peptides, HBOT, brain stimulation or pharmacological longevity cycles
- Consumer microbiome “dysbiosis” diagnoses
- Epigenetic age as definitive biological age
- Biomarker movement as proof of longer life
- Grounding as proven ATP enhancement
- Dopamine hacking or brainwave mastery
Governance
Your result can inform you. It cannot promote a public claim.
Personal data stays personal in scope.
A well-recorded comparison can improve one person’s decision. It cannot establish effectiveness for others or move a Candidate into the Operational Standard.
Changed device, algorithm or dose?
That is a new evidence object. A product update or materially changed intervention cannot inherit the earlier result without a fresh comparison.
Serious adverse evidence means HOLD.
The affected bounded claim stops pending review. Popularity, sponsorship and lawful market access cannot override safety or establish effectiveness.
Shared process: a Personal Science record may enter the Lab archive with its boundary intact, but it cannot bypass the master register, move itself into the Candidate Lab or promote a public claim. New promotions remain zero.
Starting evidence set
Sources that define the initial boundaries.
These sources do not prove every disposition on their own. They anchor design, measurement and safety boundaries for the successor candidate; each bounded claim still needs its own evidence and counter-evidence review.
- CONSORT extension for N-of-1 trials (CENT) 2015 — prospective repeated-crossover design and reporting.
- PubMed PMID 40834291 — consumer wearable validation and measurement uncertainty.
- CIE position statement on integrative lighting — timing, context and the absence of one universal target.
- FDA hyperbaric oxygen therapy safety letter — device and clinical-use boundaries.
- PubMed PMID 41049507 — passive-heat evidence and outcome boundaries.
- PubMed PMID 35068365 — cold-exposure evidence and risk boundaries.
- PubMed PMID 41768981 — photobiomodulation evidence and condition specificity.
- PubMed PMID 42324882 — neurofeedback evidence and clinical boundaries.
- PubMed PMID 36277076 — epigenetic-clock evidence and interpretation limits.
- Communications Biology article s42003-025-09301-3 — direct-to-consumer microbiome interpretation.
- ATSDR clinical overview for PFAS — clinical evaluation and management boundaries.
- Environmental Health 2025 oat beta-glucan/PFAS secondary analysis — an exploratory signal, not an established PFAS treatment or clearance protocol.
- Early grounding narrative review and small occupational study (PMID 30448083) — boundary sources that do not establish ATP enhancement or reliable clinical benefit.
- FDA non-invasive glucose wearable safety communication — watches and rings must not claim to measure blood glucose.
- FDA compounding safety-risk notice — experimental substance and peptide boundaries.
Use the method
Keep the ambition. Remove the theatre.
Titan can investigate the biological frontier without pretending every device, supplement or biomarker is a human superpower. Start with the safest useful question, predeclare what would change your mind and keep the result even when nothing happens.